Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Published Online
on August 11, 2005

Arteriosclerosis, Thrombosis, and Vascular Biology. 2005
Published online before print August 11, 2005, doi: 10.1161/01.ATV.0000181760.55269.6b
A more recent version of this article appeared on October 1, 2005
This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
25/10/2209    most recent
01.ATV.0000181760.55269.6bv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Denis, C. V.
Right arrow Articles by Lenting, P. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Denis, C. V.
Right arrow Articles by Lenting, P. J.

Submitted on June 13, 2005
Accepted on July 14, 2005

In Vivo Clearance of Human Protein S in a Mouse Model. Influence of C4b-Binding Protein and the Heerlen Polymorphism

Cécile V. Denis ; Sarah J. Roberts ; Tilman M. Hackeng ; and Peter J. Lenting *

From INSERM U.143 (C.V.D.), Kremlin-Bicêtre, France; the Laboratory for Thrombosis and Haemostasis (S.J.R., P.J.L.), Department of Haematology, University Medical Center Utrecht, Utrecht, the Netherlands; and the Department of Biochemistry (T.M.H.), University of Maastricht, Maastricht, the Netherlands.

* To whom correspondence should be addressed. E-mail: p.j.lenting{at}lab.azu.nl.

Objective--To explore the effect of the Heerlen polymorphism and C4b-binding protein (C4BP) on protein S catabolism in vitro and in vivo.

Methods and Results--Radiolabeled protein S was efficiently bound and intracellularly degraded by THP-1 macrophages, and both processes were strongly reduced in the presence of the protein S-carrier protein C4BP. To test whether C4BP displays a similar protective effect in vivo, survival experiments were performed in mice. In the absence of C4BP, radiolabeled human protein S disappeared in a biphasic manner (mean residence time [MRT] 2 hours). However, the presence of C4BP resulted in a 4-fold prolonged survival of protein S (MRT 8 hour; P<0.0001). We also applied this experimental model to recombinant protein S-Heerlen, a naturally occurring variant that contains a Ser460Pro substitution. These clearance experiments revealed a strongly decreased survival of recombinant protein S-S460P (MRT 0.6 hours; P=0.021), which could be compensated partially by C4BP (MRT 1.4 hours; P=0.012 compared with protein S-S460P).

Conclusion--Protein S-S460P has a reduced survival in vivo, which may explain the low levels of free protein S in individuals carrying this polymorphism. Furthermore, C4BP prevents premature clearance of protein S and uses this ability to compensate the increased clearance of protein S-S460P.




This article has been cited by other articles:


Home page
BloodHome page
C. J. van Schooten, S. Shahbazi, E. Groot, B. D. Oortwijn, H. M. van den Berg, C. V. Denis, and P. J. Lenting
Macrophages contribute to the cellular uptake of von Willebrand factor and factor VIII in vivo
Blood, September 1, 2008; 112(5): 1704 - 1712.
[Abstract] [Full Text] [PDF]